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Background: To determine if major depressive disorder (MDD) in older primary care patients is an independent risk
factor for cardiovascular events.
Methods: A cohort of 143 primary care patients with depression and 139 non-depressed controls without depression
(both aged over 55 years, matched for age and gender) from the Netherlands was evaluated for 2 years. MDD was
diagnosed according to DSM-IV–criteria. During the follow-up period, information was collected on physical health,
depression status and behavioural risk factors. CVD end points were assessed with validated annual questionnaires and
were crosschecked with medical records.
Results: Thirty-four participants experienced a cardiovascular event, of which 71 % were depressed: 27/134 with MDD
(20.1 %) and 9/137 controls (6.6 %). MDD was associated with a hazard ratio of 2.83 (p value 0,004, 95 % CI 1.32 to 6.05)
for cardiovascular events. After adjustment for cardiovascular medication, the hazard ratio was 2.46 (95 % CI 1.14 to 5.30).
Conclusions: In a 2-year follow-up period, baseline MDD increased the risk for CVD in older primary care patients
compared with controls, over and above well-known cardiovascular risk factors.
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The World Health Organization (WHO) projects that
both cardiovascular disease (CVD) and major depressive
disorder (MDD) generate the greatest loss of ‘disability-
adjusted life years’ in 2030 [1]. CVD is a leading cause of
death worldwide [2]. However, whether MDD is also an
independent risk factor for the onset of CVD remains
controversial [3–5]. With MDD being a possible modifi-
able risk factor for CVD, more research is necessary to
examine to what extent MDD poses a risk for the onset
of CVD and by what mechanism it functions.
Only a few of the studies that take into account a large
number of risk factors have examined longitudinal asso-
ciations between MDD and CVD. Studies with positive* Correspondence: hpj.vanhout@vumc.nl
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unless otherwise stated.associations show much heterogeneity in methodology
and outcomes. Two studies found an association but
only among elderly women [6, 7]. Ariyo found an in-
creased risk but only for those with the highest mean
depression score [8], whereas Penninx found an associ-
ation for newly depressed but not for chronically de-
pressed patients [9]. MDD is positively associated with
excess mortality [5, 10]. Luukinen could only find an as-
sociation between MDD and subsequent sudden cardiac
death [11]. However, in a 12-year prospective cohort
study among elderly non-institutionalized Australians,
depression was not associated with CVD incidence or
mortality [12].
The screening of over 5000 Dutch persons aged 55+
years visiting their general practitioner (GP) showed a
high prevalence of 14 % of MDD among this group, with
only 23 % being treated with antidepressants [13]. MDD,
CVD and their risk factors are all prevalent in older adults.
We, therefore, wanted to examine in a prospective 2 yearl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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indeed have an increased risk of developing CVD, and, if
so, whether the increased risk is independent of other
known risk factors for cardiovascular events.
Methods
Study design
This longitudinal two-year prospective cohort study
compared 143 primary care patients with depression and
139 non-depressed controls without depression (both
aged over 55 years), on the primary endpoint of CVD
morbidity and mortality.
Setting
This study was conducted in 14 general practices in the
Netherlands, from February 2002 to July 2003.
Participants
The eligibility criteria were that patients fulfilled criteria
for MDD according to the Diagnostic and Statistical
Manual of mental disorders IV (DSM-IV). The exclusion
criteria included severe cognitive impairment (Mini-
Mental State Examination score below 18), treatment for
current depression or treatment within the past six
months (antidepressant therapy or psychotherapy) and
treatment for psychosis.
Sources and methods of selection
Individuals of 55 years of age or older visiting one of the
participating general practices were recruited by means
of a two-stage screening procedure as previously de-
scribed in detail [14]. This two-staged screening was
considered the most practical approach. Firstly, individ-
uals were sent a validated depression screening question-
naire (n = 6719): the Geriatric Depression Scale 15-item
(GDS-15) [15]. Secondly, respondents (n = 4301) who
scored five points or more (N = 843) on the GDS-15
were asked to participate in a diagnostic interview by a
trained interviewer using the validated Primary Care
Evaluation of Mental Disorders (PRIME-MD, range 0–9)
[16]. The participating MDD patients were matched on
sex and age to a person with a negative GDS-15 score
of less than five. One week prior to the physical exam-
ination, the severity of the depressive symptoms was
measured with the Montgomery Åsberg Depression
Rating Scale (MÅDRS) [17]. Controls with a score of
ten or higher (n = 11) on the MÅDRS, and MDD pa-
tients who scored under 10 (n = 8) were excluded from
the comparison.
Follow-up
During the follow-up period of 24 months, data were
collected every 6 months by means of a) telephone inter-
views for the psychopathological and cardiovascularmeasures and b) written questionnaires for the lifestyle
domains. All participants gave their written informed
consent prior to inclusion in the study. The ethical com-
mittee of the VU University Medical Centre approved
the study.
Matching criteria and number of controls per case
Of the 432 potential participants with depression, 300
with depression were expected to be available (20–25 %
non-response) for interviews and half was expected to
have MDD. The screening and interview procedure re-
sulted in the inclusion of 143 primary care participants
with MDD and the exclusion of 62 persons.
Variables
Outcomes
CVD included ischaemic heart disease (acute myocardial
infarction, angina pectoris or chronic ischaemic heart
disease: ICD-10 code I20-25), cerebrovascular disease
(transient ischaemic attack (TIA) or stroke: ICD-10 code
I60-69 and G45), and other (heart failure, conduction
disorders and vascular disease: I34-37, 45-50, 71-77). A
previous history of CVD was assessed by asking the par-
ticipants if they had ever had a heart attack or other
heart condition, vascular disease, TIA or stroke. Inde-
pendent interviewers assessed CVD events through
interviewing the participants and these were cross-
checked with the GP medical files to determine the time
of the event. All events were coded according to the
International Classification of Diseases, Tenth Revision
(ICD-10).
Exposures
At baseline, a trained independent interviewer used a
structured interview and performed physical and labora-
tory examinations. More details of the methods are de-
scribed elsewhere [14]. The interview and physical and
laboratory examinations covered:
a) Demographics
b) CVD disease status. This was determined by asking
about actual CVD, medical history and the presence
of hypertension, hypercholesterolemia and diabetes
mellitus.
c) Cardiovascular medication was classified according
to the Anatomical Therapeutic Chemical classification
(ATC code). Use of beta-blockers, calcium antagonists,
ACE-inhibitors, diuretics and other medications within
the C category of the ATC system was taken as
additional evidence of CVD or cardiovascular risk
factors (yes/no).
d) Lifestyle factors such as smoking (current smoker or
non-smoker) and physical inactivity (the modified
Baecke questionnaire for elderly) [18].
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blood pressure (SBP, DBP), ii) body mass index
(BMI), iii) heart rate variability (HRV) which is the
standard deviation of all NN intervals on the
electrocardiogram (ECG): HRV SDNN ln. HRV may
be a prognostic factor for CVD and be more
prevalent among depressed patients [19]; iv) fasting
glucose (FG), v) High and Low Density Lipoprotein
(HDL and LDL) and vi) inflammation markers such
as CRP and interleukin-6 (IL-6) [20–22].
f ) Psychopathology. To evaluate whether patients
fulfilled MDD criteria according to DSM-IV, we used
the validated PRIME-MD interview. The severity of
observer-rated depressive symptoms at baseline was
measured with the MÅDRS. Anxiety was assessed
with the anxiety scale of the Hospital Anxiety
Depression Scale (HADS-A) [23].
All of the above exposure variables were tested in bi-
variate association with the onset of CVD among per-
sons with MDD and controls.
Study size
In a sample of older adults, we assumed to find at least
28 % new cardiovascular events in 3 years in the MDD
sample and 14 % in the controls [24]. With α = 0.05 and
β = 0.2, and the expected percentage difference for new
CVD events of 14 % (28–14 %), a control-group of 145
would provide sufficient power to answer our question.
Quantitative variables handling
Variables not normally distributed were log-linear trans-
formed (SDNN, triglycerides, CRP, IL_6).
Statistical methods
To determine whether and to what extent the elderly
GP participants with MDD had an increased risk of
developing CVD over controls (the primary hypothesis),
we first compared baseline variables. Differences in demo-
graphic, cardiovascular, psychiatric, lifestyle and physio-
logical factors between depressed and non-depressed
subjects were evaluated using Student’s t-test for continu-
ous data and Chi-square test for dichotomous data.
To examine the effect of MDD on time to cardiovas-
cular event and adjust for confounding, we computed
the amount of cardiovascular events occurring within
the follow-up period in MDD participants and controls
with Cox regression models. To assess whether potential
confounders influenced the risk of CVD associated with
depression, we included variables into the model that
were significantly different at baseline and had signifi-
cant bivariate associations with cardiovascular events.
Data were analysed using SPSS 20 and two-tailed test α
levels of <.05 were used to define statistical significance.We checked effect modification between prior CVD sta-
tus and depression by adding an interaction term.
Results
Participants
A total of 6719 persons was screened for depressive
symptoms using the GDS-15. Of the approached GP pa-
tients, 293 were identified to have MDD. Of these pa-
tients, 187 were eligible and 76 % of them participated
in our study (n = 143). The non-participants (ineligible,
refused) had a comparable gender distribution (66.7 vs.
64.0 % female), but were older (71.55 vs. 67.59 years) and
had a lower average PRIME-MD score (5.86 vs. 6.37) than
the 143 participating index participants. Fig. 1 presents a
flowchart of the recruitment.
Descriptive data
Participant characteristics are briefly presented in Table 1.
The matching process was not entirely successful as 99
women (69 %) and 44 men (31 %) were included in the de-
pressed group and 90 women (65 %) and 44 men (35 %) %
in the controls (p 0.423). Background characteristics
showed that the two groups were comparable, except that
participants with MDD lived alone more often than con-
trols (X2 = 12.44, p < 0.001). Both groups had a somewhat
increased CVD risk at baseline. The prevalence of diabetes
was higher among depressed patients than among controls
(X2 = 5.75, p 0.017), but fasting glucose levels did not dif-
fer, indicating that the diabetics were properly treated for
their condition. Pertaining to lifestyle factors, participants
with MDD were physically more inactive as shown by
their lower mean Baecke physical activity score (p <
0.001). The following physiological factors were different:
BMI levels were 28.2 (SD 5.2) kg/m2 and 26.8 (SD 4.2),
with a statistically significant difference at p 0.0018, and
the MDD group had a lower mean HRV as measured on
an ECG (p 0.023). Depressed and non-depressed partici-
pants showed no differences in cholesterol levels or other
physiological parameters.
Depressed participants reflected prevalent cases (81.0 %
with a history of depression), but many of the controls
also had such a history (45.7 %, (X2 = 37.73, p < 0.001).
As was to be expected, cases scoring much higher on
the MÅDRS (reflecting our case–control design) had
greater co-morbid anxiety (average four points higher
on HADS-A) (t12.25, df = 279, p < 0.001) and were five
times more likely to report a panic attack in the last
month (X2 = 22.37, p < 0.001) than controls. Anxiety
levels of HADS-A of 9.9 (SD 2.9) and 6.0 (2.5) were in
the moderately high range.
Outcome data
During the follow-up period of on average 743 days, 36
cardiovascular events were registered: 27 among the
Fig. 1 The cumulative survival of controls and depressed cases over a 2 year follow-up
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ticipants (Table 2). Ischaemic heart disease was the cause
of 9.0 % (n = 13/143) and 0.7 % (n = 1/139) of cardiovas-
cular events in the depressed and the non-depressed
group, respectively. Cerebrovascular events accounted
for 1.4 % of events in the depressed group versus 2.9 %
in the non-depressed group. 7.7 % of events in the de-
pressed group were due to other cardiovascular disease,
in comparison to 3.6 % in the non-depressed group.
Eight participants died during the follow-up period,
three of cardiovascular disease (two depressed partici-
pants and one non-depressed participant) and one
depressed participant of non-cardiovascular disease.
Four-deaths were due to unknown reasons, and all oc-
curred in the depressed group.
Main results
In bivariate analysis between covariates and cardiovascular
events in on average 743 days, depression and a history of
CVD increased the hazard ratio for cardiovascular events
significantly (Table 1). Depression had an unadjusted haz-
ard ratio (HR) for CVD events in older general practice
patients of 2.83 (95 % confidence interval (CI) 1.32 to
6.05). As the MADRS score was highly correlated with de-
pression status (Pearson correlation 0.79), we excluded it
from the analyses. Only CVD medication at baseline was
significantly associated with both baseline depression sta-
tus and outcome and remained in the model. After adjust-
ment for CVD medication, the hazard ratio decreasedslightly to 2.46 (95 % CI 1.14 to 5.30). Other models
showed similar slight reductions in HR for depression on
cardiovascular events. Survival curves according to the
adjusted Cox model are shown in Fig. 2. No evidence for
effect modification between prior CVD status and depres-
sion was seen.
Discussion
In this study on the longitudinal association between de-
pression and cardiovascular diseases, we found that older
general practice patients with major depressive disorder
were significantly more likely to have a cardiovascular
event during two years of follow-up than non-depressed
elderly participants. CVD medication confounded the as-
sociation between MDD and CVD events, but other
known risk factors, including co-morbid CVD, lifestyle
factors and physiological factors did not.
Previous investigations on the association between de-
pression and CVD events have had mixed results [7], or
even no result [25]. A recent systematic review of fifteen
studies with people without heart disease who were ex-
posed to depression concludes that most but not all
studies find an association between depression and car-
diac outcome. Our estimate seems higher than their
overall relative risk (RR) estimates of approximately 1.5
(0.64 to 6.9) for developing an acute coronary syndrome.
Our impression is that depression seems to act more as
an independent risk factor to cardiovascular events, ra-
ther, than promote them through indirect means [26].
Table 1 Differences in baseline characteristics between participants (n, %)
Category Risk factor MDD Controls Adjusted HR (95 % CI)
Background Age, y, mean (SD) 67.9 (8.7) 67.6 (7.5)
Gender (male) 44 (30.8) 49 (35.3)
Living alone** 72 (50.3) 41 (29.7)
Education (low) 55 (38.5) 62 (44.6)
Religion (yes) 70 (49.0) 64 (46.0)
CVD status CVD* 31 (25.6) 19 (14.1)
Hypertension 54 (44.6) 48 (35.6)
Hypercholesterolemia 32 (26.4) 31 (23.0)
Diabetes* 14 (11.6) 5 (3.7)
Family history of CVD 56 (39.2) 56 (40.3)
CVD medication** 85 (59.4) 62 (40.6) 2.54 (1.19 to 5.44)
Chron. illnesses, mean (SD)* 3.9 (2.3) 3.1 (2.1)
Lifestyle Smoking current 32 (22.4) 19 (13.7)
Baecke, mean (SD)** 5.42 (5.09) 7.86 (5.17)
Physiology (mean, SD) BMI, kg/m2* 28.17 (5.21) 26.76 (4.16)
SBP, mmHg 146.2 (18.05) 142.4 (18.56)
DBP, mmHg 83.62 (9.41) 83.72 (8.17)
HRV SDNN ln*, ms 1.50 (0.25) 1.57 (0.24)
Total cholesterol, mmol/l 5.98 (1.15) 6.02 (1.08)
Fasting glucose, mmol/l 5.64 (1.13) 5.56 (0.96)
LDL cholesterol, mmol/l 3.54 (1.07) 3.74 (0.94)
HDL cholesterol, mmol/l 1.65 (0.51) 1.60 (0.41)
Triglycerides, mmol/l 1.76 (1.16) 1.55 (0.92)
IL-6 ln, pg/ml 0.95 (0.63) 0.86 (0.62)
CRP ln, mg/l 1.02 (1.08) 0.77 (1.08)
Psychiatry MADRS, mean (SD) ** 19.38 (8.25) 2.73 (3.89)
HADS-A, mean (SD) ** 9.92 (2.89) 5.98 (2.46)
Panic disorder** 36 (25.4) 7 (3.2)
Depression history** 115 (81.0) 63 (45.7)
Family history depression* 58 (40.6) 39 (28.1)
*, p < 0.05; **, p < 0.01
Table 2 CVD events and mortality
Event (ICD-10 code) MDD Controls
(N = 143), % (n = 139), %
Ischaemic heart diseasea (I20-25) 13 (9.0) 1 (0.7)
Other CVDb (I34-37, 45-50, 71-77) 11 (7.7) 5 (3.6)
Cerebrovascular diseasec (G45, I60-67) 3 (2.1) 3 (2.2)
No event 107 (74.1) 128 (92.1)
Death with unknown cause (R99) 4 (2.8) 0 (0.0)
Missing data 5 (3.5) 2 (4.4)
aIncludes angina pectoris, acute myocardial infarction and chronic ischemic disease
bIncludes conduction disorders, heart failure, nonrheumatic valve disorders
and aortic aneurysm/dissection
cIncludes transient ischaemic attack and stroke (ischemic and non-ischemic)
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ship seems to point in this direction. The role that car-
diovascular drugsdrug play in this relationship requires
further study.
Strengths and limitations
The longitudinal nature of the data allows insight into
the relationship between depression and cardiovascular
diseases over time. Due to the relatively short follow-up,
the relatively small numbers of participants and the lim-
ited numbers of events, we were only able to apply a
simple association model. An interesting comparison
would be to study whether older patients treated for de-
pression have a better cardiovascular prognosis. More
research is needed with longer follow-up time to allow
Fig. 2 Flow chart of the recruitment of participants
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study is one of the few studies that used a general prac-
tice population, the factors we studied are relevant. The
sampling may partly explain why so many participants
had a high CVD-risk at baseline. These were mostly pa-
tients in GP care for their chronic conditions. Lack of
confirmation of the PRIME-MD diagnosis by clinician
interview is a final limitation.
Conclusions
In conclusion, we found that MDD is a risk factor for CVD
in older primary care patients, over and above other well-
known cardiovascular risk factors. Within a 2 year follow-
up period, there was an almost threefold increase in CVD
onset among depressed patients compared with controls.
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